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Background: Dementia is a major cause of cognitive impairment in the elderly. Numerous studies have
investigated the association between hypertension and cognitive disorders in elderly persons, with
inconsistent results. The goal of the study was to investigate the association between hypertension at
baseline and cognitive impairment after 24 months’ follow-up in the elderly residents of the Kahrizak
Charity Foundation (KCF) in Iran.
Methods: There were 211 elderly residents of KCF aged 65 years or older with a Mini Mental State
Examination (MMSE) score greater than 10. The MMSE score was assessed at the end of the study. Blood
pressure was measured in all of the participants at the beginning of study. Data were compared between
hypertensive and normotensive patients.
Results: A total of 63.5% of patients had impaired cognition (61% and 63.9% in normotensive and
hypertensive patients, respectively). Cross sectional analysis of baseline data in a multiple regression
model has revealed that diastolic high blood pressure was a risk factor for cognitive impairment even
after adjustment for confounding factors (odds ratio: 2.42, 95% CI: 1.01-5.78). In the cohort follow-up
analysis, the relative risk of cognitive impairment for patients aged 75 years or older with ﬁnal diag-
nosis of hypertension was 0.72 (0.57e0.92). The relative risk of patients with systolic high blood pressure
and history of hypertension was 19% and 10%, respectively, which was lower than normotensive group
but such differences were not signiﬁcant.
Conclusions: High systolic blood pressure in very old persons may have a preventive effect on devel-
opment and progression of cognitive impairment. However, diastolic high blood pressure perhaps may
be a risk factor for cognitive impairment in elderly persons.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Dementia is one of the most disabling neurologic disorders of
aging populations. It is a progressive disorder characterized by
impairment of memory and at least one of the intellectual functions
of the brain severe enough to interfere with daily activities and
independence1. The burden of the disease tends to increase in
parallel with increased life expectancy, and by 2040 it will account
for 81.1 million cases worldwide2. Symptomatic therapy currentlyerest.
erly Health Research Center,
ehran University of Medical
gar Avenue, Tehran, Iran.
eh).
iwan Society of Geriatric Emergenis the mainstay of disease management and no curative strategies
are available. The progressive and irreversible nature of the disease
sheds light on the importance of identiﬁcation and primary
prevention of risk factors3,4.
Alzheimer disease (AD) and vascular dementia (VaD) contribute
to approximately 60% and 26%, respectively, of all dementia
syndromes5. Numerous longitudinal and cross-sectional studies
have demonstrated the association between cardiovascular disease
(CVD) risk factors, i.e., diabetes mellitus, hypertension, dyslipidemia,
obesity, and smoking, with AD and VaD as the leading causes of
dementia6e10. Therefore, by taking appropriate measures aimed at
prevention, early detection, and treatment of CVD risk factors,
cognitive declinewill no longer be an inevitable component of aging.
Hypertension is a common disorder among elderly adults and its
prevalence tends to rise as the population ages. Hypertension iscy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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is a heterogeneous disorder including multi-infarct dementia, stra-
tegic infarct dementia, and subcortical ischemic dementia12. The
common features among these clinical syndromes are athero-
thrombosis or cardiogenic embolism in large- and medium-sized
vessels and hypertensive/arteriosclerotic angiopathy in small
vessels4,12. AD traditionally has been regarded as a primary neuro-
degenerative disorder. However, the role of vasculopathy and the
contribution of vascular risk factors to the development of AD have
received much attention in recent years13e15. Therefore, regardless
of the underlying etiologies, controlling blood pressure as a phar-
macologically modiﬁable risk factor might prevent dementia or
slow the progression of cognitive decline.
Some epidemiologic studies have addressed the relationship
between blood pressure, cognitive function, and dementia.
However, marked discrepancies exist between the results of cross-
sectional and longitudinal studies. Furthermore, apparent incon-
sistencies exist in the results of similarly designed population-based
observational studies. Positive correlation, negative correlation,
U-shaped correlation, J-shaped correlation, and no association
between blood pressure and cognition has been reported7,8,10.
The goal of the current study is to investigate the association
between blood pressure at the beginning of the study and cognitive
impairment after 24 months in elderly patients.
2. Materials and methods
2.1. Participants
All participants were 65 years or older and lived in KCF. Patients
with end-stage liver, cardiac, and renal diseases, Parkinson disease,
and severe dementia (deﬁned as obtaining scores 10 on theMini-
Mental State Examination [MMSE])16 were excluded. Informed
consent was obtained from all participants and also their ﬁrst-
degree relatives if their MMSE score was less than 22. The study
protocol was approved by the ethics committee (PM184/10/0123 K,
this Code represent the Persian calendar day with related ofﬁcial
numbers) in the Endocrinology and Metabolism Research Center of
Tehran University of Medical Sciences.
2.2. Data collection
2.2.1. Demographic and medical information
Demographic characteristics including age, sex, education level,
and smoking status and previous medical diagnosis including the
history of diabetes mellitus, hypertension, cardiovascular disease
(CVD), and strokewere obtained from participants’ medical records.
2.2.2. Medical examination
At the beginning of the study, blood pressure, height, and
weight were measured by trained nurses or research assistants.
Blood pressure measurements were performed by a tonometer
automatic sphygmomanometer (Omron 7, Tokyo, Japan) which
was calibrated by a mercury sphygmomanometer after every 100
measurements, according to the guidelines of The Seventh Report
of the Joint National Committee on Prevention, Detection, Evalua-
tion, and Treatment of High Blood Pressure (JNC 7) with the
participant in a recumbent position after 5 minutes of rest; the
average of three measurements was recorded. Participants were
advised to avoid alcohol, cigarette smoking, caffeinated beverages,
and exercise for at least 30 minutes before blood pressure
measurement. An average of three measurements was recorded at
3-day intervals during 1 week.
A history of hypertension was assumed for any participant who
was under treatment with antihypertensive drugs or if he or shehad a history of hypertension in his or her medical documents.
With this guideline, the systolic high blood pressure was deﬁned as
systolic blood pressure was 140 mmHg; diastolic high blood
pressurewas deﬁned as diastolic blood pressure90 mmHg; a ﬁnal
diagnosis of hypertensionwas assumed if either systolic or diastolic
high blood pressure or a history of hypertension existed. The
accuracy of height and weight measurements was 0.5 cm and
0.1 kg, respectively. The body mass index (BMI) was calculated as
weight (kg) divided by height squared (m2).
2.2.3. Laboratory tests
Twelve-hour overnight fasting blood samples were collected to
determine serum glucose. Serum fasting glucose was measured by
an enzymatic colorimetric technique in the fasting condition (Par-
sAzmun Kits, Tehran, Iran). In study participants, diabetes was
deﬁned according to American Diabetes Association criteria as
diagnosis of the condition in the participants’ medical records and/
or current use of hypoglycemic drugs and insulin and/or fasting
serum glucose  126 mg/dL.
2.2.4. Neuropsychologic tests
At baseline and at the end of the study, the Persian-adapted
MMSE questionnaire was used to assess cognitive status. MMSE
was assessed twice in 2 days during a week; the mean MMSE score
was calculated for each participant. The Persian standardized
version of MMSE was administered16. This consists of 11 questions
assessing a broad range of cognitive functions including orientation,
recall, attention, calculation, language manipulation, and construc-
tional praxis17. Patients’ mental status on MMSE was interpreted as
normal or impaired based on age- and education-speciﬁc norms18.
Depression was evaluated by the 15-item Persian adapted Geriatric
Depression Scale (GDS) questionnaire19,20. Both MMSE and GDS
were implemented by one trained clinical psychologist.
2.3. Follow-up protocol
All the participants were on low-salt and relative low-fat diet
regimens. Meal plan was similar in all of them due to residency in
a nursing home. Blood pressure was measured three times every 6
months based on the JNC 7 protocol using an automatic sphygmo-
manometer (Omron 7, Japan) that was calibrated by a mercury
sphygmomanometer. MMSE, GDS, and fasting blood samples for the
routine laboratory tests were obtained from participants at the start
of the study and every year thereafter. Weight and height also were
measured yearly.
2.3.1. Diagnosis
High systolic blood pressure was deﬁned as systolic blood
pressure 140 mm Hg. High diastolic blood pressure was deﬁned
as diastolic blood pressure 90 mm Hg in three separate blood
pressure measurements at baseline. If there was either a history of
hypertension in the patients’ medical records or a history of anti-
hypertensive medication use, this was considered as having
a history of hypertension. A ﬁnal diagnosis of hypertension was
considered if there was a history of hypertension, use of antihy-
pertensive medication, or a baseline systolic blood pressure of
140 mmHg or diastolic blood pressure of 90 mmHg in three
separate measurements.
2.4. Statistical analyses
SPSS version 18(Chicago, IBM) and STAT SE8 (Texas, StataCorp
Lp) were used for all analyses. Normally distributed continuous
variables were expressed as mean standard deviation and were
compared using the Student t test. Categorical data were expressed
Table 1
Characteristics of study subjects.
Normotensive
(n¼ 44)
Hypertensive
(n¼ 166)
p
Age 76.007.70 78.62 7.43 0.04*
Female (%) 40 50 0.007*
BMI 25.015.34 24.75 5.53 0.78
Education (illiterate) (%) 71.7 57 0.03*
Smoker (%) 10 12.8 0.55
Diabetes (%) 8.3 13.7 0.00*
Cardiovascular disease (%) 16.7 47.49 0.00*
Stroke (%) 13.3 12.2 0.81
GDS score 10.59 6.98 12.73 6.72 0.06
MMSE score 19.07 5.02 19.58 5.03 0.55
*p< 0.05.
BMI¼ body mass index; GDS¼Geriatric Depression Scale; MMSE¼Mini-Mental
State Examination.
Table 3
Association of systolic/diastolic high blood pressure, history, and ﬁnal diagnosis of
hypertension at baseline with cognitive impairment in cross-sectional analysis.
Unadjusted Adjusteda
OR CI OR CI
Systolic high blood pressure 0.92 0.48e1.78 0.93 0.47e1.82
Diastolic high blood pressure 2.52b 1.06e5.95 2.42b 1.01e5.78
History of hypertension 0.87 0.47e1.61 0.88 0.47e1.64
Final diagnosis of hypertension 0.89 0.41e1.90 0.90 0.42e1.92
CI¼ conﬁdence interval; OR¼ odds ratio.
a Adjusted according to age, sex, body mass index, smoking, history of stroke, and
cardiovascular disease by forward condition method.
b Signiﬁcant at p< 0.05; in multiple logistic regression model.
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< 0.05 was considered statistically signiﬁcant. Comparisons of the
means of blood pressure between impaired and normal cognitive
groups were performed using the Student t test. A logistic regres-
sion model was used to study the association between cognitive
impairment (dependent variable) and systolic/diastolic high blood
pressure, history, and ﬁnal diagnosis of hypertension (independent
variables) at baseline. The results were expressed as odds ratio and
conﬁdence interval. In cohort analysis, the relative risk was calcu-
lated; the existence of high systolic and diastolic blood pressure
and hypertension at the onset of the study was identiﬁed as an
exposed variable. Sensitive analysis was done to assess the effect of
lost to follow-up on study ﬁndings.
3. Results
3.1. Demographic and medical characteristics
The clinical characteristics of the participants are shown in
Table 1. A total of 211 cases were included; 85 were males with
amean age of 76.64 6.99 years and 126were females with amean
age of 79.06 7.76 years. Smoking status, BMI, history of stroke,
and GDS and MMSE scores were similar between hypertensive and
normotensive groups. However, there were signiﬁcant differences
between the two groups with regard to age, sex, educational level,
diagnosed diabetes mellitus, and history of CVD (Table 1).
3.2. Cognitive function
Accordingly, 61.5% of participants had impaired cognition. There
was no signiﬁcant difference between impaired cognition in hyper-
tensive and normotensive groups (61% and 63.9%, respectively).
3.3. Blood pressure and cognitive function
Systolic, diastolic, and mean blood pressures were higher in
impaired cognitive groups than normal cognitive groups. However,
the differences were not signiﬁcant (p> 0.05) (Table 2).Table 2
Mean values of systolic, diastolic, and mean blood pressures between subjects with
normal and impaired cognition.
Cognition
Normal
Mean SD
Impaired
Mean SD
p
Systolic blood pressure (mmHg) 132.24 23.6 135.55 27.68 0.49
Diastolic blood pressure (mmHg) 75.44 12.63 77.13 15.62 0.51
Mean blood pressure (mmHg) 94.64 15.21 96.52 18.36 0.55
SD¼ standard deviation.3.4. Cross-sectional analysis
Cognitive function showed no signiﬁcant association with
systolic high blood pressure, history, or ﬁnal diagnosis of hyper-
tension (categorized variable). However, diastolic high blood
pressure was a risk factor for cognitive impairment (odds ratio 2.42,
p< 0.05) after adjustment for sex, BMI, smoking, history of stroke,
and cardiovascular disease. The results are summarized in Table 3.
3.5. Risk analysis
Cognitive impairment relative risk has been calculated for the
following variables: systolic and diastolic high blood pressure,
history of hypertension, and ﬁnal diagnosis of hypertension. In
addition, these values were estimated in those younger than 75
years and in those 75 years and older (Tables 4e6). The relative risk
of cognitive impairment for ﬁnal diagnosis of hypertension is
signiﬁcantly lower than 1 (0.72) in the second group (p< 0.05).
3.6. Loss analysis
Fifty-three participants who were enrolled in this study died;
two others left the institute and were lost to follow-up. The mean
blood pressure of the participants who died was not signiﬁcantly
different from that of the living participants. In addition, there were
no signiﬁcant differences between theMMSE scores of persons who
died and living participants (Table 7). In addition, sensitive analysis
was performed with two assumptions. First, all of the participants
who died or were lost to follow-up were assumed to be in the
impaired cognition group, and the relative risk of impaired cogni-
tion for ﬁnal diagnosis of hypertension was calculated to be 0.89
(0.95% conﬁdence interval 0.75e1.06). Second, we assumed that the
mental status of participants who died or were lost to follow-up did
not change during the follow-up period, and the relative risk of
impaired cognition for ﬁnal diagnosis of hypertension was calcu-
lated to be 0.85 (0.95% conﬁdence interval 0.68e1.06).
4. Discussion
In this study we assessed the relation of cognitive impairment,
which was deﬁned based on the MMSE cutoff point, with hyper-
tension in a cohort follow-up study. The MMSE cutoff point was
calculated based on age and education-speciﬁc norms. At baselineTable 4
Relative risk of cognitive impairment for hypertension components exposure.
Exposed variable Relative risk 95% CI of RR p
History of hypertension 0.90 0.71e1.15 0.16
Systolic high blood pressure 0.81 0.61e1.06 0.09
Diastolic high blood pressure 1.12 0.86e1.46 0.53
Final diagnosis of hypertension 0.80 0.63e1.01 0.07
CI¼ conﬁdence interval; RR¼ relative risk.
Table 5
Relative risk of cognitive impairment for hypertension components exposure in
patients younger than 75 years.
Exposed variable RR 95% CI of RR p
History of hypertension 0.78 0.49e1.22 0.81
Systolic high blood pressure 0.89 0.55e1.44 0.79
Diastolic high blood pressure 1.15 0.71e1.86 0.65
Final diagnosis of hypertension 0.81 0.53e1.24 0.78
CI¼ conﬁdence interval; RR¼ relative risk.
Table 7
Comparison of exposure and outcome variable in alive, dead, and discharged groups
(ANOVA).
Alive group
n¼ 155
Dead group
n¼ 53
Discharged
group
n¼ 2
p
Systolic blood pressure 134.72 25.76 139.07 22.86 135 10 0.53
Diastolic blood pressure 77.06 14.80 78.73 13.68 75 5 0.73
History of hypertension 57.7% 67.9% 50% 0.22
Final diagnosis of
hypertension
76.9% 84.9% 100% 0.36
MMSE score 19.73 4.95 18.89 5.63 23.5 3.53 0.38
ANOVA ¼ analysis of variance; MMSE ¼ Mini-Mental State Examination.
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participant groups in terms of mean age, sex, education level, CVD,
and diabetes. Some of these differences, such as sex and education
level, were randomized and some others such as CVD may be
ascribed to complications of hypertension. This ﬁnding is obvious
because of the higher prevalence of CVD in hypertensive compared
with normotensive participants. In cross-sectional analysis of base-
line data, diastolic high blood pressure was a strong risk factor for
cognitive impairment even after adjustment for sex, age, BMI,
smoking, history of stroke, and CVD. In cohort analysis after 24
months, the relative risk of diastolic high blood pressure was more
than 1 but it was not signiﬁcant. This ﬁnding may indicate that
diastolic blood pressure of 90 mmHg or greater in elderly patients
is a risk factor for cognitive impairment. The same results were re-
ported in a recent cross sectional analysis21.
The relative risk of cognitive impairment in patients with
hypertension, systolic high blood pressure, and history of hyper-
tension were respectively 20%, 19% and 10% lower than normo-
tensive subjects. However, these ﬁndings were not statistically
signiﬁcant with a 95% conﬁdence interval. Nevertheless, in those 75
years or older, there was a 28% and 24% lower relative risk for ﬁnal
diagnosis of hypertension and systolic high blood pressure
respectively than normotensive ones. Perhaps this ﬁnding indi-
cated that a ﬁnal diagnosis of hypertension (hypertension history or
presence of systolic or diastolic high blood pressure), which was
deﬁned as hypertension history and the presence of systolic
and diastolic high blood pressure, had a preventive effect on the
development or progression of cognitive impairment in older
persons.
This discrepancy between the effect of high systolic and diastolic
blood pressure on cognitive impairment can probably be explained
by the effect of systolic blood pressure on brain tissue perfusion, but
apparently the diastolic blood pressure does not have a similar
effect22.
Guo et al23, in a population-based study with 1736 participants,
have reported that those older than 75 years with increasing
systolic blood pressure tend to have a lower risk of cognitive
impairment, and this effect was retained in a level of 180 mmHg
systolic blood pressure. However, diastolic blood pressure
95 mmHg was a risk factor for cognitive impairment.
Some studies have revealed a positive correlation between
elevated blood pressure and cognitive impairment/dementia,
including the large-scale Atherosclerosis Risk in Communities
study, which used systolic blood pressure of at least 160 mmHg toTable 6
Relative risk of cognitive impairment for hypertension components exposure in
patients 75 years or older.
Exposed variable RR 95% CI of RR p
History of Hypertension 0.95 0.71e1.27 0.48
Systolic high blood pressure 0.76 0.54e1.05 0.15
Diastolic high blood pressure 1.11 0.81e1.51 0.78
Final Diagnosis of hypertension 0.72* 0.57e0.92 0.04
* p< 0.05.
CI¼ conﬁdence interval; RR¼ relative risk.deﬁne hypertension24. However, impaired cognition has been re-
ported with moderately increased blood pressure in the absence of
clinically evident target organ damage25.
As mentioned previously, vascular risk factors contribute to the
development and progression of VaD and AD6e10.
Extensive review of the literature, including both cross-sectional
and longitudinal studies, in addition to the results of clinical trials
evaluating the effect of antihypertensive medications, provided
sufﬁcient valid evidence to formulate a plausible hypothesis. It has
been postulated that long-standing hypertension beginning in
midlife is implicated in the development of late-life cognitive
impairment and dementia. On the contrary, elderly patients with
hypertension are less prone to the development of cognitive
impairment and dementia. This seemingly paradoxic effect is partly
due to the protective role of elevated blood pressure in cerebral
perfusion in elderly patients with stiffer arteries and the progres-
sive decline in blood pressure as a consequence of established
dementia7,8,10.
In the clinical setting, restricted control of hypertension might
not have a beneﬁcial effect on cognitive decline in elderly patients.
Therefore, in the analysis of cognitive impairment prevention,
overemphasis on blood pressure control may not have any
implication.
Some limitations of the current study deservemention. First, the
inadequate number of participants was a major limitation to make
further conclusions, especially because we could not categorize the
participants in more than four categories for age and level of blood
pressure. Second, assessment of mental status by using one
instrument was another limitation of this study. Although the
MMSE is the most commonly used instrument for screening of
cognitive status in elderly patients26, it was better to use two
instruments instead of one. Using an instrument that was less
dependent on education level of the participants was desirable.
The strengths of our study were rigid control of background
factors such as similarity of diet regimen in all of the participants
and few patients lost to follow-up.
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